|
|
||||||||
Letters |
Department of Pathology and Laboratory Medicine, Cayuga Medical Center at Ithaca, 101 Dates Dr., Ithaca, NY 14850, Fax 607-274-4481, E-mail JSN{at}CORNELL.edu
To the Editor:
In the process of establishing a troponin I assay in our
laboratory, we found limited data on reference intervals for
plasma. Because our laboratory relies heavily on plasma rather than
serum to expedite analysis (1), we undertook a parallel
study of serum and plasma troponin I concentrations with the
Abbott AxSYMTM assay. To our surprise,
we found several discordant results (Table 1
). Reanalysis of the samples reproduced the discrepant
results. However, when one of the serum samples was recentrifuged,
reanalysis produced results essentially the same as those obtained from
the matching plasma sample. After the other discordant serum
samples were recentrifuged and reanalyzed, all serum and plasma results
were similar. Additional samples, purposely allowed to contain tiny
fibrinstrands, also produced increased troponin I results.
|
We believe that the antibody either binds nonspecifically to fibrin or that the indicator enzyme is physically trapped by fibrin in the separation matrix. Because incomplete separation of serum can leave fibrin in the sample, falsely increased troponin I concentrations can result.
We concluded that the use of plasma rather than serum essentially eliminates this problem and also allows the samples to be placed on the AxSYM faster, expediting turnaround time by at least 1015 min. However, if serum is used, the samples must be completely clotted and centrifuged sufficiently to ensure complete separation of the serum from the clot. In our laboratory, we have found that centrifugation at 2000g for 10 min is required for the preparation of fibrin-free serum.
References
Abbott Laboratories, 200 Abbott Park Rd., Abbott Park, IL 60064
a Address correspondence to this author at: Abbott Laboratories, 200 Abbott Park Rd., Building AP31, Department 9JW, Abbott Park, IL 60064.
To the Editor:
This letter highlights the important issue of sample preparation and that poor sample integrity can adversely affect assay methodologies, regardless of the highly specific nature of the reagents. For assays using serum, it is important to ensure that complete clot formation has taken place before centrifugation. It should also be noted that some specimens, especially those from patients receiving anticoagulant or thrombolytic therapy, may exhibit increased clotting time. If specimens are centrifuged before complete clot formation, the presence of fibrin may alter results.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. L. Piekarz, A. R. Frye, J. J. Wright, S. M. Steinberg, D. J. Liewehr, D. R. Rosing, V. Sachdev, T. Fojo, and S. E. Bates Cardiac Studies in Patients Treated with Depsipeptide, FK228, in a Phase II Trial for T-Cell Lymphoma. Clin. Cancer Res., June 15, 2006; 12(12): 3762 - 3773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Wallace, E. Hausner, E. Herman, G. D. Holt, J. T. Macgregor, A. L. Metz, E. Murphy, I.Y. Rosenblum, F. D. Sistare, and M. J. York Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity Toxicol Pathol, January 1, 2004; 32(1): 106 - 121. [PDF] |
||||
![]() |
J. Kamblock, L. Payot, B. Iung, P. Costes, T. Gillet, C. Le Goanvic, P. Lionet, B. Pagis, J. Pasche, C. Roy, et al. Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels Eur. Heart J., May 1, 2003; 24(9): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brown, M. D. Vukovich, E. R. Martini, M. L. Kohut, W. D. Franke, D. A. Jackson, and D. S. King Endocrine and Lipid Responses to Chronic Androstenediol-Herbal Supplementation in 30 to 58 Year Old Men J. Am. Coll. Nutr., October 1, 2002; 20(5): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Peetz, G. Hafner, and K. J. Lackner Analytical Characteristics of the AxSYM Cardiac Troponin I and Creatine Kinase MB Assays Clin. Chem., July 1, 2002; 48(7): 1110 - 1111. [Full Text] [PDF] |
||||
![]() |
A. Cerutti, L. Corsini, R. Finotto, and C. Perazzi Comparison of Cardiac Troponin I in Serum and Heparin Plasma with the Dimension RxL Assay Clin. Chem., May 1, 2002; 48(5): 790 - 791. [Full Text] [PDF] |
||||
![]() |
G. A. Brown, E. R. Martini, B. S. Roberts, M. D. Vukovich, and D. S. King Acute hormonal response to sublingual androstenediol intake in young men J Appl Physiol, January 1, 2002; 92(1): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Beyne, J.-P. Vigier, P. Bourgoin, and M. Vidaud Comparison of Single and Repeat Centrifugation of Blood Specimens Collected in BD Evacuated Blood Collection Tubes Containing a Clot Activator for Cardiac Troponin I Assay on the ACCESS Analyzer Clin. Chem., November 1, 2000; 46(11): 1869 - 1870. [Full Text] [PDF] |
||||
![]() |
H. Stiegler, Y. Fischer, J. F. Vazquez-Jimenez, J. Graf, K. Filzmaier, B. Fausten, U. Janssens, A. M. Gressner, and D. Kunz Lower Cardiac Troponin T and I Results in Heparin-Plasma Than in Serum Clin. Chem., September 1, 2000; 46(9): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galambos, D. S. Brink, D. Ritter, H. D. Chung, M. H. Creer, and K. A. Ford False-Positive Plasma Troponin I with the AxSYM Analyzer The manager of AxSYM System Integration for Abbott Diagnostic Division responds: Clin. Chem., July 1, 2000; 46(7): 1014 - 1015. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |